Drug therapies tailored to the DNA profiles of individual patients could change the face of medicine, but such treatments aren't commonly used in the clinic
The Scientist
Most Recent
Two sisters—Kate, a developmental biologist, and Helen, a high-end fashion designer—team up to develop a couture collection inspired by the first 1,000 hours of embryonic life. Dubbed Primitive Streak—after the early embryonic process that results in
Is DNA damage an inevitable consequence of epigenetic reprogramming?
Postdoc forced to leave position after questioning the reproducibility of advisor's data
A snapshot of the most highly ranked articles in vaccination and related areas, from Faculty of 1000
New compounds are showing promise in targeting subpopulations of cancer stem cells
Pitfalls and triumphs on the way to complete vaccine protection.
When someone snorts or smokes cocaine, which is composed of small crystalline alkaloid molecules, the drug enters the bloodstream and from there eventually crosses into the heart, brain, and other organs. Cocaine quickens heart and respiratory rates,
Like other enveloped viruses, HIV exits its host cell enshrouded in the cell’s membrane, which contains membrane molecules such as the human leukocyte antigens (HLA). The HLA proteins act as a set of cell identification marks: every person expresses
Follow The Scientist
Stay Connected with The Scientist
-
The Scientist Magazine
-
The Scientist Careers
-
Neuroscience Research Techniques
-
Genetic Research Techniques
-
Cell Culture Techniques
-
Microbiology and Immunology
-
Cancer Research and Technology
Current Issue
